|
ATP6V1B2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.258600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.162300E-03 |
| Normal-vs-Stage2 |
3.133000E-01 |
| Normal-vs-Stage3 |
1.051960E-02 |
| Normal-vs-Stage4 |
6.42920000000213E-05 |
| Stage1-vs-Stage2 |
1.895780E-01 |
| Stage1-vs-Stage3 |
4.778200E-01 |
| Stage1-vs-Stage4 |
2.065600E-02 |
| Stage2-vs-Stage3 |
1.064630E-01 |
| Stage2-vs-Stage4 |
1.982720E-03 |
| Stage3-vs-Stage4 |
8.729800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.464900E-03 |
| Normal-vs-AfricanAmerican |
8.502500E-03 |
| Normal-vs-Asian |
5.230300E-02 |
| Caucasian-vs-AfricanAmerican |
9.762000E-01 |
| Caucasian-vs-Asian |
2.825400E-01 |
| AfricanAmerican-vs-Asian |
2.414000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.198600E-03 |
| Normal-vs-Female |
2.977300E-03 |
| Male-vs-Female |
2.949400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.019200E-04 |
| Normal-vs-Extreme_Weight |
4.816500E-03 |
| Normal-vs-Obese |
7.364800E-03 |
| Normal-vs-Extreme_Obese |
7.080600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.433200E-01 |
| Normal_Weight-vs-Obese |
2.428200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.829620E-01 |
| Extreme_Weight-vs-Obese |
6.633800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.849800E-01 |
| Obese-vs-Extreme_Obese |
3.502000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.976200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.007790E-02 |
| Normal-vs-Age(61-80Yrs) |
5.389200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.581500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.715200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.665800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.802400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.660400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.994000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.047200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.719700E-03 |
| Normal-VS-Type2 PRCC |
2.390200E-01 |
| Normal-VS-KIRP CIMP |
2.08509999999329E-05 |
| Normal-VS-Unclassified PRCC |
3.194500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.634410E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.530100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.805000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.68789999999542E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.074600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.135500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.243240E-01 |
| Normal-vs-N1 |
4.04250000000106E-05 |
| Normal-vs-N2 |
3.424300E-02 |
| N0-vs-N1 |
6.369700E-04 |
| N0-vs-N2 |
9.455900E-02 |
| N1-vs-N2 |
4.370800E-01 |
|
|
